The state of knowledge of health effects from low-dose exposures to ionizing radiation has recently been reviewed in extensive reports by three prestigious national and international commissions of scientific and medical experts with partially overlapping membership, known by their acronyms UNSCEAR (United Nations Scientific Committee on the Effects of Atomic Radiation)(1), BEIR V (Biological Effects of Ionizing Radiation) (2) , and ICRP (International Commission on Radiological Protection) (3) . Publication of these reports was followed by a number of summaries in scientific journals, authored by recognized radiation experts, that purport to present a scientific consensus of lowdose effects in a more accessible format for health professionals. A critical comparison between various presentations of accepted views, however, reveals inconsistencies regarding "established" facts and unsettled questions (4) .
In 1990 the BEIR V Committee (composed of 17 experts on radiation epidemiology, bioeffects, and risk estimation) issued a more than 400-page report (2) which serves as a widely quoted and prestigious review of low-dose radiation health effects. In the body of this report, the committee acknowledges some critical areas of uncertainty and controversy, particularly with regard to estimates of radiogenic risk pertaining to anthropogenic increases in lowdose exposures above unavoidable natural background levels, both occupational and environmental. Obviously, such estimates are of the greatest importance to guidelines for the protection of public health. Yet, within the BEIR V report, we find inconsistencies between the committee's conclusions, as stated on different pages. Moreover, few of these obviously unresolved questions found their way into the most widely quoted Executive Summary.
Subsequent authoritative overviews in scientific journals have not only glossed over some of these inconsistencies in the BEIR V report, but they also present different views of what constitute "well established" and "unproven" aspects of low-dose health effects. We highlight some of these inconsistencies by quoting or paraphrasing statements from the BEIR V report and comparing them with assertions on the same topics from three subsequent journal reviews, all citing BEIR V as a major source. Editorial comments, reflecting on the citations, have been placed in square brackets. In our discussions, "low doses" means the dose range well below 50 cGy.
We select five controversial issues in the debate about protracted low-dose exposures to illustrate our point.
BEIR V Shape ofa dose-effect curvefor cancer induction. In several places of its report (2) , the BEIR V Committee concurs with the large team of scientists at the Radiation Effects Research Foundation in Hiroshima, Japan, which has collected and analyzed the Life Span Study (LSS) of A-bomb survivors for decades: after a one-time (acute) exposure, a linear, nonthreshold relation between excess mortality from cancers, except leukemia, and dose gives an excellent fit to the 1950-1985 LSS data, if restricted to doses below 200 cGy. However, BEIR V "recognizes that its risk estimates become more uncertain when applied to very low doses," and the committee concedes rather obliquely that "departures from a linear model at low doses, however, could either increase or decrease the risk per unit dose" (2.-6).
Dose-rate effectivesness factor at low doses. In its report, the BEIR V Committee states: "For low-LET radiation [low linear energy transfer, such as from [ and y radiation], accumulation of the same [total] dose over weeks or months, however, is expected to reduce the lifetime risk appreciably, possibly by a factor 2 or more" (2: 6) . Such a downward correction for linearly extrapolated risk values is called DREF (dose rate effectiveness factor).
On the next page, however, we read:
While experiments with laboratory animals indicate that the carcinogenic effectiveness per
Gy of low-LET radiation is generally reduced at low doses and low dose rates, epidemiological data on the carcinogenic effects of low-LET radiation are restricted largely to the effects of exposures at high dose rates. Continued research is needed, therefore, to quantify the extent to which carcinogenic effectiveness of low-LET radiation may be reduced by fractionation or protraction of exposure. Fifteen pages later, the committee states: "There are scant human data that allow an estimate of the dose rate effectiveness factor (DREF)" (2: 22) . Then, in a subsequent section the report picks up the same topic:
Since the risk models were derived primarily from data on acute exposures. . . the application of these models to continuous low doserate exposures requires consideration of the dose rate effectiveness factor (DREF).... For the leukemia data, a linear extrapolation indicates that the lifetime risks per unit bone marrow dose may be half as large for continuous low dose rate as for instantaneous high dose rate. For most other cancers in the LSS, the quadratic contribution is nearly zero, and the estimated DREFs are near unity. Nevertheless, the committee judged that some account should be taken of dose rate effects and in Chapter Most human exposures to low-LET ionizing radiation are to X-rays, while the A-bomb survivors received low-LET radiation in the form of high energy gamma rays. These are reported to be only half as effective as orthovoltage X-rays. While that is not the conclusion of this Committee, which did not consider this question in detail, it could be argued that since the risk estimates that are presented in this report are derived chiefly (or exclusively) from the Japanese experience they should be doubled as they may be applied to medical, industrial, or other X-ray exposures. (2: 218) The physical basis for such a possible effect is the roughly fourfold higher ionization density in tissue by medical X-rays than that by high-energy 7-rays (6) .
Role offree radicals in tumorigenesis by ionizing radiation. Regarding the role of free radicals in tumorigenesis, the report states: "To the extent that the effects of radiation are mediated by free radicals, which can also mediate the effects of promoting agents, sequential exposures to radiation may serve to promote tumorigenesis through mechanisms similar to those of chemical promoting agents" (2: 139).
The report gives no further consideration to the question, whether radiogenic free radical production, in particular, at low doses and low dose rates could link protracted low-level exposures to various diseases or immune depression, known to be promoted by these highly reactive chemical species (7) .
Radiation hormesis. On page 383 the report states: Although "beneficial" effects of radiation have been alleged on the basis of reduced mortality in high background areas in the United States, analyses that include an adjustment for altitude indicate no 'beneficial' effects.... This apparently "beneficial" effect of radiation may, in fact, be an example of confounding... (2: 383) The first of the three summaries in Table 1 was published in a journal for public health professionals by members of the BEIR V Committee (8) . Hence its statements conform largely with the BEIR V report, except for some significant omissions. The other two summaries (9, 10) in Table 1 show deviations, as well as omissions, compared to the BEIR V report. They have been directed to physicians and radiologists in general. The usefulness of reviewing unanswered questions after BEIR V for the purpose of identifying new directions for investigations was recently recognized by other researchers in the field (11) . This paper is predicated on the premise that a special focus on unrefuted positive associations of very low-dose exposures with health effects that are inconsistent with long-held notions will suggest unorthodox hypotheses. Testing these hypotheses will require investigations in yet insufficiently explored areas that are likely to reveal a greater-than-expected complexity of interactions between lowdose radiation exposures, other environmental toxics, and disease.
Because of their dominance in shaping prevalent notions about the effects of radiation, we briefly review the findings from the A-bomb survivor study, with particular emphasis on low-dose effects. In subsequent sections we summarize some studies that are pertinent to our above-stated premise. standards, national and international radiation regulatory commissions had to resort to models for downward extrapolation to reasonable levels of occupational exposure from the well-established high-dose observations. Those models were also influenced by data from limited follow-up studies of patients who had received high doses of radiation for therapeutic purposes. By implicitly postulating the existence of a universally valid dose-effect relation and by generalizing from high-dose experiments on much shorter-lived rodents to human response at much lower doses, the ICRP (12) , UNSCEAR (13) , and BEIR III (14) reports in the late 1970s all concluded either explicitly or implicitly that linear, no-threshold extrapolation from high-dose A-bomb survivor mortalities would, in fact, overestimate low-dose radiogenic risks. For fractionated low-dose exposures (thus for most occupational and environmental exposures), the radiation committees recommended that linearly extrapolated risk values should subsequently be corrected (divided) by dose-rate effectiveness factors (DREFs) of at least a factor 2, with the greatest risk reduction to be applied to the lowest doses and/or dose rates.
Follow-up
However, microdosimetric analyses have shown that at decreasing doses, the concept of dose rate loses its meaning entirely because of the discrete nature of the radiation-cell interaction: the smallest possible effect must be caused by a single cell traversal (15, 16 bias of unknown origin in the occupational data in order to set aside their own findings if they differ from those derived from LSS statistics (24) . Scant attention has been given to evidence in the RERF data that these discrepancies might reflect unrecognized intrinsic incommensurabilities in health profiles (such as lasting selection effects after the initial disaster in Hiroshima and Nagasaki, combined for some survivors with permanent immune depression) and age distributions between the LSS cohort and a worker population-quite apart from the vastly different characteristics of irradiation (25, 26) . Adopting the LSS findings as a universal standard also implies the untested hypothesis that a single dose-effect relationship can Induction of mutations in human cells is a nonthreshold linear function of dose, independent of dose rate. The dose-response for induction of breast cancer is linear without threshold. While there are several epidemiological studies that have purported to show carcinogenic or leukemogenic effects of irradiation in the dose range below 10 cGy, there are no theoretical reasons, nor are there supporting animal data , or low-dose A-bomb survivor data in the range 1-9 cGy suggesting that there should be a convex upward dose relation, that would be required to observe a rapidly rising cancer incidence at very low doses, close to natural background.
The dose-rate effect for induction of specific gene mutations in human cells may be significantly less than that observed in rodent cells. Nevertheless, when the experimental data are considered along with limited epidemiologic data, a DREF of 2 has been recommended for chronic exposures. However, little or no decrease in risk was observed for induction of breast cancer, when the dose was received in a protracted manner, as opposed to a single brief exposure.
[Not mentioned.]
Ionization results in the production of free radicals that are extremely reactive and may lead to permanent damage of affected molecules.
A lack of correlation between cancer incidence and background radiation was observed in different studies. Low-dose epidemiologic studies in populations of limited size must be carefully controlled, and are often prone to bias by confounding factors.
describe all conditions of exposure (23) .
Evaluation of incremental excess cancer risk from mortalities among the lowest dose subcohorts. Linear extrapolation models used by BEIR V and RERF to predict low-dose risk values can be checked by a straightforward analysis of mortality data, limited to the lowest dose subcohorts. The methods used in all official analyses of A-bomb mortality data have weighted the resulting risk values toward those observed in the medium-to high-dose range (22) . Recently, two groups of researchers published independent analyses that were restricted to cancer mortalities among the A-bomb survivors who had been exposed to less than 50 or 100 cGy (16, 28, 29) . These low-dose subcohorts Environmental Health Perspectives --9_-. -_-9- 9 99 include about 80% of the entire LSS cohort. Using the 1950-1985 follow-up data (30) (Fig. 1) .
The distribution of survivors according to sex and age at exposure does not vary by more than a few percent across the relevant low-dose subcohorts (29) . Consequently, for the limited purpose of inspecting the gross features of the dose-response relation, aggregate mortalities were analyzed, introducing only negligible systematic errors. Weighted linear regression analysis over the dose ranges listed in Table 2 and displayed in Figure 1 (DS86, 1950 (DS86, -1985 follow-up) that contradict the validity of applying a DREF to low-dose exposures are as follows: 1) Both the A-bomb survivor cancer mortality and incidence data fail to suggest the existence of a threshold for cancer induction down to very low doses (19, 35, 36) .
2) Doses less than 5 cGy and probably as low as 1.6 cGy have been associated with excess cases of leukemia (ALL and CML) among A-bomb survivors (34,3X). CA detailed discussion of this estimation is given in Nussbaum and K6hnlein (28, 29 Table 2 ). The two dashed lines are weighted linear fits to the two data points for the combined 0-5 and 6-19 cGy dose groups (see Table 2 ) and the three data points for the dose groups 6-19, 20-49, and 50-99 cGy with mean doses above 10 cGy (see Table 2 ), respectively. 
well below the maximum permissible dose. For another group of cancers, they found a slightly negative association with dose, an effect that remained unexplained at the time. The authors concluded that 1) low-dose, low dose-rate radiogenic cancer risks appear to be 10-20 times greater than those extrapolated from the A-bomb survivor study, 2) workers within the nuclear industry are an the whole considerably healthier than the general population, and within the workforce, those who perform the riskier (and higher paid) jobs are healthier than the average worker (external and internal healthy worker effect), 3) Two earlier studies in which the same group of workers was followed through 1977 found no association between radiation dose and cancer mortality (59, 60) . Apart from having incorporated 7 more years of follow-up, the Wing et al. (20) study considered the effects of various controlling factors in greater detail.
Some negative reactions to the the Oak Ridge worker study were reminiscent of those to the first Hanford worker study (50) (20) .
There are other mortality studies of workers in British nuclear establishments (41, 42) Cancers among commercial airline pilots. Airline pilots are subject to cosmic radiation, accumulating yearly doses up to about 1 cGy, or the equivalent of three to four times natural background for an average U.S. citizen . A cancer mortality and incidence study among about 900 Canadian male pilots showed significant excess rates for several cancers, including Hodgkin's disease and nonmelanoma skin cancer (66) . By using a standardized mortality ratio (SMR) analysis with the population of British Columbia as the control group, the positive findings represent underestimates of excess incidence and mortality rates because the reported healthy worker effect (SMR 0.80 for all causes of death) was not taken into account. Individual dose estimates were not included in the analysis; thus the findings suggest, but do not firmly establish, an association with exposure to low doses of ionizing radiation, possibly in synergism with exposures to a range of electromagnetic frequencies and, for rectal cancer, with a high-fat diet. High altitude exposure and/or aviator status also correlate significantly with cancerous conditions of the skin, testicles, bladder, and thyroid in a study of U.S. pilots (67) . A study of chromosome aberrations induced in lymphocytes of pilots and stewardesses also confirms effects of very low-dose exposures in this occupation (68) .
Given the large number of pilots and the readily available data on flight times, elevations and monitored intensities of cosmic radiation, this group presents a unique opportunity to extend epidemiological studies at low doses to these populations worldwide.
Possible genetic effects of low-dose exposures. Gardner and co-workers (69, 70) (76) (77) (78) (79) . The indications for genetic effects from preconceptual parental exposures are in part consistent with earlier findings of elevated risks for several diseases for children whose parents had been exposed to diagnostic X-rays.
While some types of birth defects showed significant association with parental employment at Hanford but not with monitored parental preconception doses, other defects showed a significant association with parental accumulated occupational exposures. Taken together, the data were in part contradictory, and the authors interpreted them as false positives (80) . An 4 and 7 years were associated with prenatal obstetric X-ray examinations, with an estimated average dose of about 0.5 cGy in the 1950s. The dose per examination declined significantly over subsequent years. The resulting excess risk from prenatal X-ray examinations of the fetus was estimated to be about 20 deaths per 104 person-cGy, with a three times higher risk for exposure during the first trimester of pregnancy than during the last trimester (82) (83) (84) (85) (86) . This fetal risk factor during the first trimester is about nine times that given by BEIR V for a general population (2). Also, there remains an unexplained discrepancy between in utero radiogenic cancer risks for a normal population of children in Great Britain and for prenatally exposed children ofA-bomb survivors who were still alive in 1950 (87) . On that basis, the OSCC team's claim of a causal relation between fetal exposures and induction of excess childhood cancers was rejected for decades. Meanwhile, Stewart and Kneale (25, 26) presented evidence from the LSS data that could explain the lack of concordance on account of significant differences between populations and their post-exposure experiences. A U.S. tri-state leukemia survey found parental preconception and prenatal exposures of children to diagnostic X-rays to be associated with increased risks for leukemia and a number of other diseases in children (88) .
Childhood mortalities and external background radiation. In the past, a number of studies claimed lower cancer mortality rates in geographic locations with higher background exposures. Such findings have been cited to claim beneficial effects of low-dose radiation (hormesis) (89) . However, when a number of such studies, based on U.S. vital statistics data, were critically analyzed, the authors concluded: "When we adjust linearly for altitude, the negative correlations between mortality and background radiation all disappear or become positive. . . . We see no support here for the claim that ionizing radiation is beneficial at low doses" (90: 388). Nevertheless, a second international conference on hormesis, held in Kyoto, Japan, in July 1992, attracted about 250 scientists from all over the world.
With fetal tissue being particularly sensitive to radiation during its earliest period of development (85) 
. This study suggests that "background radiation might be an element of the causal chain of the majority of childhood cancers" (91: 16) . It is noteworthy that a simple regression analysis of childhood cancers found a negative correlation with dose, in qualitative agreement with the above-mentioned studies with inadequate controls for confounding factors that continue to be cited in support of radiation hormesis. When confounding socioeconomic factors, identified as being strongly correlated with childhood cancer mortality, were included in the OSCC analysis, the association with background dose turned significantly positive.
Consistent with the British OSCC results, a recent U.S. study also found a significant association between childhood cancer incidence and a variation in annual external background -ray dose rate by nearly a factor two (0.05-0.092 cGy per year) over an area within a radius of approximately 10 miles from the Three Mile Island nuclear plant. On the basis of risk factors derived from the A-bomb survivor study, no detectable trend in cancer among children should have been found from variations in background exposures of such small magnitude. This study, however, found a 50% increase in risk of cancer for children under 15 years with every 0.01 cGy increase in estimated annual background 7-ray dose (92) . As in the British background study above, the high sensitivity to radiation is most likely related to exposures during the earliest fetal stages of development.
Increased cancer risk after scalp irradiation by X-rays. Modan et al. (93) found an increased risk of cancer for the most recent 5-year period of a long-term follow-up study of Israeli children who had scalp irradiation for tinea capitis between 1949 and 1959. The original cohort included 10,834 irradiated children. Estimated mean doses were 9 cGy to the thyroid, 4.8-6.6 cGy to the pituitary, and 1.6 cGy to the breast. Until 1982 there were no indications of an increased cancer risk compared to matched controls. Since then, however, incidence of breast cancer increased significantly, showing a long latency period for induction in childhood. A high relative risk of about 12 (with a large uncertainty) was found in women who had been exposed to a mean breast dose of 1.6 cGy at age 5-9 years. Thyroid cancers eventually became also more frequent in the exposed population.
Environmental Contamination from Radioactive Fallout
In contrast to the extensive epidemiological literature pertaining to solid cancer and leukemia induction from well-defined and MO9 == (controls) . The authors estimated active bone marrow dose from external exposure to radioactive deposition on the soil from fallout to range from 0 to 3.0 cGy. The median bone marrow dose for all cases and controls was 0.32 cGy, compared to a dose of 0.49 cGy from terrestrial and cosmic background radiation accumulated over the period of fallout (7 years) . A significant association with external marrow dose was found for acute leukemias discovered from 1952 to 1963 among those individuals who were younger than 20 years at exposure. The observed risks at these low exposures are about double those predicted by the BEIR V (2) model, but the difference was not statistically significant. The results are, however, consistent with several previous studies of populations exposed to fallout from the Nevada atmospheric bomb tests (94) . While a positive association was observed between leukemia and external exposure, internal exposures from ingested fission products might well play a dominant role if tissue concentrations of radioisotopes can be assumed to be correlated with levels of external contamination.
Also, a statistically significant excess of thyroid neoplasms was found among schoolchildren from communities in southwest Utah, southeast Nevada, and southeast Arizona, potentially exposed to fallout between 1951 and 1958. Estimated doses from radioactive iodine isotopes to the thyroid ranged from 0 to 460 cGy (17 cGy average for Utah ) (95) .
Leukemia clusters near civilian nuclear power plants. An (99, 100) .
Leukemia in the United States andfallout from nuclear testing. Levels of depositions of low levels of fission products such as strontium-90 from atmospheric nuclear explosions have been found to be associated with increased leukemia rates among children. The strongest association of a composite exposure index that used strontium-90 concentrations in food, cow's milk, and human bone was found with acute and myeloid leukemia rates about 5.5 years after the peaks in fallout among 5-9 year olds. Regional differences in leukemia rates corresponded to different levels of the exposure index. The leukemia rates fell again sharply after the cessation of atmospheric tests (101) .
Radioactive emissions and breast cancer. Breast cancer mortality rates for the years 1984-1988 were found to be associated with documented cumulative airborne releases of fission products (including iodine-131, strontium-90, strontium-89, and cesium-137) from nuclear power plants in nine census regions of the United States during the period 1970-1987. Assuming the average inhaled or ingested radioactivity (i.e., internal dose) to be directly correlated with these releases, the authors found approximately a logarithmic relationship between mortality and exposure (102) . Such a supra-linear doseresponse relationship for internal exposure in a dose range, estimated to be of the order of external yearly background (if confirmed), would be qualitatively consistent with a proposed disease mechanism that involves biochemical chain reactions in human tissue, progressing from oxygen free-radicals produced at low dose rates of ionizing radiation and subject to saturation concentrations (14, 103) .
In light of the special sensitivity of the developing fetus and breast tissue to radiation, a direct link between ingestion of radioisotopes by the pregnant mother and subsequent birth outcomes or induction of breast cancer provides a plausible explanation for the above observations, provided that other time-correlated confounding factors can be reasonably excluded.
Radioactive fallout and congenital defects. 1) A discontinuity in historical trends for early infant (neonatal) mortality in West Germany before April 1986 and after fallout from the Chernobyl reactor accident had reached western Europe showed a significant association with higher levels of fall-out in southern as compared to northern Germany (104) (105) (106) . The authors' proposed causal association of infant mortality with environmental radioactive contamination involving the food chain has been significantly strengthened by another, completely independent study.
2) First-day infant mortality, firstthrough sixth-day infant mortality, and stillbirth statistics have been followed for England and Wales (110) . The international team had relied on questionable health records supplied by the government of the former Soviet Union, rather than on hospital records, the study population did not include the thousands of "reactor liquidators," and the controls were chosen from areas of the same general district that had been only slightly less contaminated.
The IEAE experts' conclusion stands in marked contrast to clinical reports from Minsk (Belarus) of an alarmingly large and persisting increase of particularly invasive thyroid cancers in children shortly after the Chernobyl accident (111 (110) (the same study that related a broad spectrum of diseases among that population to radiophobia) found no significantly elevated levels of such aberrations in the blood of similarly exposed populations. This finding was supported by Neel et al. (118) . However, the latter team used for their controls a population with a 10 times higher background level of aberrations than that usually quoted in the relevant literature. These authors postulate that the appearance of "rogue" lymphocytes (cells with multiple aberrations) has a viral origin, while the findings by Scheid 
Conclusions and Discussion
A number of findings reviewed in the previous sections are at variance with the summaries of the "state of knowledge," which have been primarily based on official interpretations of the A-bomb survivor followup study. Neither the fetal hypersensitivity to radiation, nor an increase in susceptibility for cancer induction for an aging population are part of the accepted notions on radiation effects at low doses. Nor does this body of assumptions link low-dose exposures resulting from radioactive fallout (either from nuclear testing or from reactor accidents) to any of the observed congenital effects reported. When Presumed reduced biological effectiveness of ionizing radiation. The occupational exposure studies reviewed here, the prenatal X-ray and external background exposure studies, as well as the studies related to airborne radioactive emissions, are all inconsistent with the hypothesis of reduced biological effectiveness of ionizing radiation at protracted irradiation .
Enhanced biological effectiveness ofmedical X-rays relative to high-energy y-rays.
Environmental Health Perspectives= -. 9
-. -9.-9 -9 . X-rays compared to cesium-137 y-rays, and there is a physical basis for expecting such a difference in biological effectiveness. The significance of these radio-biological findings for human exposures is an unsettled question with broad ramifications for radiation protection. Free radicals, low-dose exposures and health. Except for mentioning the possible creation of free radicals by ionizing radiation in the BEIR V report and by one of the reviews cited, the possibility that this interaction and disturbance of intracellular communication could provide a strongly nonlinear alternative biological mechanism to the well-known direct mutational interactions of radiation with human cell nuclei in the induction of disease-in particular, at very low doses-has not become part of the discussions of low-dose radiation effects, in spite of a burgeoning literature linking free-radicals to a wide spectrum of diseases, as well as suggesting possible treatments (7, 103, 121 
